DEMYLOCAN
Google image searchProduct monograph
Active ingredient
decitabine, 50 MG/VIAL
DIN: 02484811
Dosage form(s): POWDER
Route(s) of administration: INTRAVENOUS
Schedule: Prescription
Company: PENDOPHARM DIVISION OF PHARMASCIENCE INC
Date: 24-MAR-2021
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01B — ANTIMETABOLITES (ATC, ATC/DDD)
- L01BC — Pyrimidine analogues (ATC, ATC/DDD)
- L01BC08 — DECITABINE (ATC/DDD)
Reference brand drug: Demylocan
